VIKTORIYA KHAITOVA: Open Payments
NPI 1982823514 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 23 payments from 6 companies in 2025. Trend: 2023 $486 · 2024 $305 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $321 |
| Ipsen Biopharmaceuticals, Inc | 5 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| PFIZER INC. | 1 | $36 |
| ABBVIE INC. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
Products named: IQIRVO, Yeztugo, XIFAXAN, TICOVAC, MAVYRET, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
